Page last updated: 2024-08-26

dimyristoylphosphatidylglycerol and Neoplasms

dimyristoylphosphatidylglycerol has been researched along with Neoplasms in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Ahiwale, RJ; Chellampillai, B; Pawar, AP1
Iseki, S; Kato, T; Matsumoto, Y; Nakano, K; Suzuki, H; Ueoka, R1

Other Studies

2 other study(ies) available for dimyristoylphosphatidylglycerol and Neoplasms

ArticleYear
Investigation of 1,2-Dimyristoyl-sn-Glycero-3-Phosphoglycerol-Sodium (DMPG-Na) Lipid with Various Metal Cations in Nanocochleate Preformulation: Application for Andrographolide Oral Delivery in Cancer Therapy.
    AAPS PharmSciTech, 2020, Oct-09, Volume: 21, Issue:7

    Topics: Administration, Oral; Animals; Antineoplastic Agents; Biological Availability; Calorimetry, Differential Scanning; Cations; Diterpenes; Doxorubicin; Drug Carriers; Female; Humans; Nanoparticles; Neoplasms; Particle Size; Phosphatidylglycerols; Rats; Rats, Wistar; Sodium; Solubility; Tissue Distribution

2020
[Specific inhibitory effects of hybrid liposomes on the growth of various tumor cells].
    Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan, 1999, Volume: 119, Issue:4

    Topics: Animals; Cell Division; Depression, Chemical; Dimyristoylphosphatidylcholine; Humans; Liposomes; Neoplasms; Phosphatidylglycerols; Polyethylene Glycols; Tumor Cells, Cultured

1999